The morphologic analysis of 100 early squamous cell carcinomas of the esophagus has shown that the barely visible Accurate endoscopic staging is possible using morphologic criteria, superficial spread, and rigidity of the wall as parameters. In a prospective study, we show that the degree of accuracy of this staging system reaches 95% for an experienced endoscopist.
INTRODUCTION
Compared with that in China, Iran, and other Eastern countries, the incidence of esophageal carcinoma is much lower in Europe (< 10/100,000) (Siewert et al., 1977) . A systematic screening with sponge or balloon cytology is therefore unadvisable. The only exception to this rule applies to patients with head and neck cancer, up to 97% of whom consumed tobacco and alcohol. For other groups of patients, endoscopy remains practically the only chance to diagnose an early asymptomatic esophageal carcinoma. This endoscopic screening should be integrated in the routine daily work of gastroenterologists and head and neck surgeons. This is why endoscopists should be well aware of the different morphologic patterns of early squamous cell carcinomas of the esophagus .
MATERIAL AND METHODS
Our experience has been gathered from a systematic endoscopic and histopathologic study of 100 early squamous Address for correspondence: Dr P. H. Monnier, Otolaryngology, Head & Neck Surgery, CH-1011CHUV Lausanne, Switzerland. Phone: 41.21.314.46.40, Fax: 41.21.314.46.43 cell carcinomas of the esophagus over a 15-year period (1977-1992) . Most of these lesions were diagnosed in patients during endoscopy before or after treatment for head and neck cancer, 48 being synchronous and 34 metachronous early second primaries. In only 13 cases did the endoscopist detect the early cancer as an isolated lesion.
Technical Details of the Endoscopic Examination
In head and neck cancer patients, the notion ofcommon risk factors (tobacco and alcohol consumption) is coupled with the tendency to develop multifocal lesions. This implies the need not only for endoscopy of the esophagus, but for that of the mouth, pharynx, and tracheobronchial tree. The basic requirements of this pretherapy endoscopic screening are:
1. high expertise of the endoscopist;
2. exploration of the whole mucosal surface exposed to carcinogens, with special attention to high-riskregions; 3. high quality optical instruments (Hopkins system) and efficient methods of histologic sampling; and 4. capability of detecting early lesions in their inframacroscopic stage (epithelial dysplasia, carcinoma in situ, and microinvasive carcinoma) with the use of vital staining, for example. This oncologically oriented endoscopy calls for a various number of special instruments that provide optimal exploration at all levels of the upper aerodigestive tract. Practically speaking, the patient arrives on an out-patient basis in the morning, fasts, and leaves the clinic in the early afternoon. Examination of the oral cavity and pharynx is carried out using a surgical microscope before and after Toluidine blue gargle. This vital staining procedure, accomplished in less than five minutes, is done in three steps. (1) washing or multiple swabbing with 1% acetic acid (mycolysis); (2) 1-minute washing or swabbing with 1% Toluidine blue (staining); and (3), thorough rinsing with 1% acetic acid (decolorization).
This method aids in directing biopsy sites and in determining the exact extent of a suspicious cancerous lesion. It also facilitates screening of early second primary cancers devoid of macroscopic signs (epithelial dysplasia, carcinoma in situ). The limits of the method must, however, be taken into consideration (several false-positives and one false-negative) (Table 1) .
For the pharyngolarynx, the surgical microscope and laryngeal mirror or the Hopkins 90 angle optics (Von Stuckrad indirect laryngoscope) are of considerable help, because they provide a detailed dynamic examination of the high-risk zones with the use of vital staining.
The patient then undergoes general anesthesia. Bronchoscopy is performed first, using both a rigid bronchoscope and a fiberscope. Because the two instruments are complementary, it is possible to perform an optimal quality tracheobronchoscopic examination that offers outstanding optical quality and instrumentation, possibilities for examining the larger bronchi using the rigid bronchoscope, peripheral examination, and biopsy of lesions located distal to the segmentary bronchi using the fiberscope.
If a suspicious lesion is detected in the pharyngolaryngeal region, direct examination is performed with a surgical microscope and a Toluidine blue test. However, the anatomic configuration of this region with its folds and recesses increases the risk of staining artifacts.
Finally, hypopharyngoesophagoscopy is performed using a rigid esophagoscope equipped with Hopkins optics; Toluidine blue is applied systematically to every suspicious lesion. The rigid instrument seems essential for this exploration, because it provides optimal spreading of the mucosa in the recesses of the pharyngolaryngeal region where saliva tends to stagnate, constituting high-risk cancer zones as well as of the sphicter regions. To be completely reliable, the Toluidine blue staining procedure (similar to that performed in the oral cavity) must be done in three steps. Owing to the superior instrumentation possibilities using the rigid endoscope, staining is carried out under optimal conditions, whereas with the gastrofiberscope, the technical difficulties introduce serious problems in the interpretation of a possible lesion such as the impossibility of achieving mechanical decoloration using a cotton swab soaked in acetic acid. If one wishes to use a gastrofiberscope, the Lugol iodine solution is preferable, because it is easier to use. The Lugol iodine solution is a negative tumor marker that does not stain epithelial dysplasias and carcinomas in situ, because these precancerous lesions are devoid of the glycogen present in normal squamous cell epithelium (Mori et al., 1993 (Table 2) .
Most often, the fundamental lesions are characterized by both a color change (leucoplakia or erythroplakia) and a surface alteration (elevated or depressed). There exists, moreover, a relationship between these two morphologic characteristics: an elevated lesion is generally associated with a leucoplakia, whereas a depressed lesion usually shows up as a reddish lesion at endoscopy (erythroplakia). However, an esophageal carcinoma in situ can be fiat (no surface alteration) and show no color change; this is called the "invisible" form (or "occult" according to the Chinese) of early esophageal cancer.
After the combined study of the morphologic aspects of the fundamental lesions and their mapping, we classify early esophageal carcinomas into four types (Siewert etaL, 1977) .
Figure la, b Plakelike form of early esophageal cancer with hardly any surface alteration, a) Although this invasive form of early cancer hardly shows any surface discoloration, the plakelike rigidity of the mucosa is suspicious for a submucosal infiltration, b) After Toluidine blue staining, the lesion is somewhat better visualized, but the uptake of the dye is only partial.
Leucoplakia
The distinctive morphologic element is the localized and elevated surface alteration, associated with a whitish discoloration. Usually, the lesion is unique and quite distinct from the surrounding normal mucosa. Toluidine blue staining is of minimal help in this type, because the surface keratosis keeps the dye from penetrating into the mucosa. The superficial extension generally is moderate, and multicentricity is absent or minimal. On the other hand, intraluminal growth and deep infiltration of the organ wall are common, especially ifthis plakelike lesion originates from severe dysplasia of the basal layers of the epithelium with early infiltration of the basal cell membrane and with an intact superficial layer of the epithelium. For this reason, endoscopic distinction between a carcinoma in situ and a cancer that has already infiltrated the submucosa is not easy. The slightest rigidity of the wall is a sign of submucosal invasion. (Fig. 1) . Erythroplakia This is the most common type, although often it is barely visible. The dominant feature of this lesion is the reddish discoloration, which is in general diffuse and slightly depressed compared with the surrounding normal mucosa. Given the multicentricity and diffuse nature of the lesion, it is impossible to determine the exact extent of the lesion without the use of vital staining. In these cases, use of Toluidine blue as a tumor marker is of particular help in determining the precise limits of the tumor, which often is multicentric, and for directing biopsy. These lesions are characterized by their superficial spread, which is often extensive (several cm2), whereas intraluminal and intraparietal growth appear only later.
It is important to note that a perfectly fiat erythroplakia can correspond to multiple microinvasive cancer foci. The multicentricity of the lesion exists not only at the stages of dysplasia and carcinoma in situ but also in the invasive stage (Fig. 2) (Fig. 4) . 
Histology Method
Given the approximately 80% rate of multicentric tumors and the fact that it is impossible to microscopically determine the zones of maximal invasion, a histopathologic examination of step sections of the surgical specimen is necessary in all cases of early cancer.
The specimen is colored using 1% Toluidine blue solution immediately after surgical removal in the operating room. The stain shows less affinity for poorly vascularized tissue, and too long a delay between the time of specimen excision and vital staining can result in false-negative results. The specimen is then pinned to a cork board and photographed to life size (format 1/1). After formalin fixation, all lesions are examined histologically by step sections (each 2 mm). The anatomic site ofthe sample immediately is labelled on a life-size photograph and is precisely oriented by coloring its proximal end with India ink. This provides precise evaluation of the histologic slide and an exact reconstitution of the mapping of the tumor (Fig. 5 ).
Another method of anatomopathologic examination was proposed by Mandard et al., in 1980 (Mandard et al., 1980) . It consists of painting all macroscopically visible lesions as well as those discovered by vital staining with green China ink; this makes all the pathologic zones immediately obvious on the histologic slides.
Staging of Early Esophageal Cancers
The choice of an optimal treatment modality depends on an exact endoscopic staging of the lesion. Beside endo- scopic ultrasonography, three main criteria help differentiate in situ, microinvasive, and submucosal carcinomas. These are the endoscopic aspect of the lesion, its superficial extension, and the presence or absence of a slight localized rigidity of the esophageal wall. In a prospective study of 64 cases, we checked the reliability of our endoscopic criteria in predicting the in-depth invasion of early squamous cell carcinomas of the aerodigestive tract (Monnier et al., 1991) . On the basis of these criteria, the endoscopist establishes the presumed histologic diagnosis of the lesion. Using a secret code, he stages the lesion as an intraepithelial carcinoma, as a microinvasive carcinoma not invading beyond the muscularis mucosae, or as a submucosal carcinoma.
The presumed diagnosis is passed on to the pathologist using the secret code number. The resected specimen is analyzed by serial histologic sections, and the degree of cancer invasion is measured by micrometry. The histologic diagnosis then is confronted to the endoscopic diagnosis by athird person who establishes acorrelation between the two.
RESULTS
Knowledge of the different morphologic aspects of early esophageal carcinomas plays a key role in determining the exact staging.
Among the macroscopic criteria that were studied, the color of the lesion, the superficial spread, and the parietal rigidity proved to be most useful in estimating the in-depth tumoral invasion during endoscopy.
The different fundamental lesions (occult form, erythroplakia, leucoplakia, and leucoerythroplakia) are not related to the same risk of tumor invasion (Table 3 ). The occult form is never invasive. In our series, this was confirmed in all 9 cases of early esophageal carcinomas. In another 18 cases, the same observation was made in the oral cavity and pharynx. These data are in full agreement with Chinese results on larger series of early esophageal cancers.
Pure erythroplakia is either intraepithelial or microinvasive (46 of 49 cases). Exceptionally, the in-depth invasion reaches the submucosa when the superficial extension is larger than 2 cm 2 or when slight rigidity of the wall, associated with some surface irregularity, is present. The leucoerythroplakia almost always corresponds to an invasive lesion, and a submucosal extension must be suspected in almost 40% of cases. The slightest rigidity of the wall and a superficial extension of more than 2 cm are further important signs related to submucosal extension. In the esophagus, the leucoerythroplakia thus corresponds to the most advanced type of early cancer, according to our criteria.
Leucoplakia may correspond to an intraepithelial, intramucosal, or submucosal lesion. The degree of superficial extension is usually small. The presence of localized rigidity of the wall is the only sign that helps determine the submucosal infiltration when it is present.
A particular plakelike form of early esophageal cancer can be extremely difficult to diagnose, because it does not show any surface discoloration. Only a slight plakelike rigidity of the wall, without any surface alteration, is visible. This form of early esophageal cancer derives from dysplasia of the basal layers of the squamous cell epithelium, with early invasion of the lamina propria but without any dysplastic modification of the superficial layers of the epithelium. This gives rise to an aggressive and invasive squamous cell cancer of the esophagus.
Overall, the erythroplakias and occult forms represent 58% of all early esophageal cancers (Table 3 ). This indicates that the less visible lesions occur most frequently. This probably explains the poor diagnostic yield of routine upper GI endoscopies in detecting early esophageal cancers, at least in Western countries (Froelicher and Miller, 1985) .
Superficial Extension
When a lesion shows a superficial extension less than cm2, a microinvasion is likely in only 20% of the cases. This figure rises to almost 90% if the lesion is larger than 2 cm2, whatever the fundamental lesion may be. 
Rigidity of the Wall
This sign of invasion has been observed in 16 of 17 submucosal carcinomas in this series. The only case that was underestimated corresponded to an erythroplakia with a superficial extension of more than 2 cm2. It was initially staged as an intramucosal carcinoma, because no real rigidity of the wall could be determined at endoscopy. Combining these three criteria, we were able to predict accurately or overevaluate the degree of in-depth invasion in 55 (86%) of 64 early cancers of the aerodigestive tract that were studied prospectively as described in Material and Methods. In 9 (14%) cases, the lesion was underevaluated at endoscopy, but on each occasion the underestimation was minimal. Only 3 lesions, which were considered microinvasive at endoscopy and which eventually corresponded to an invasion of more than 1 mm (twice 2 mm and once 3 mm) could be assumed to have real negative therapeutic consequences, because the submucosal extension bears a higher risk of lymph node metastasis than does an intramucosal invasion. It is interesting that the 3 underevaluated lesions corresponded to a leucoerythroplakia in 2 cases and to an erythroplakia in 1 case, which confirms their high tendency toward cancerous infiltration.
DISCUSSION Definition of Early Squamous Cell Carcinoma of the Esophagus
At present, the definition of early esophageal carcinoma is based on the empirical notion of surgical curability. Anatomically, it concerns carcinomas limited to the mucosa and submucosa without lymph node metastasis (pTaN0 and pTbN0). It is debatable, however, if submucosal carcinomas still should be considered as early cancers. First, around 70% of the cases initially present with lymph node metastasis at surgery, and second, TbN0 cancers may develop late lymph node metastasis, as we ourselves have documented in 11 consecutive cases followed up for more than 5 years.
None ofthese 11 cases showedevidence ofsecondpdmaxies in the lungs, esophagus, or upper aerodigestive tract at autopsy. This means that submucosal carcinomas ofthe esoph-agus, even without lymph node metastasis at the time of surgery, are far from having 100% cure rates. We therefore propose that the definition ofearly esophageal cancershould be restricted to in situ and intmmucosal carcinomas without lymph node metastasis (pTaN0).
Pretherapy Staging of Early Esophageal Cancer
This includes the precise evaluation of the in-depth invasion of the primary tumor and the detection of mediastinal lymph node metastasis. Furthermore, at least in Europe where the incidence of esophageal carcinoma is related to tobacco and alcohol consumption, a routine pretherapy bronchoesophagoscopy should be performed in all cases to detect synchronous early asymptomatic cancers of the oral cavity, pharynx, or tracheobronchial tree. This is especially worthwhile in former head and neck cancer patients.
As we have demonstrated above, the endoscopic staging of esophageal cancers is based on the morphology, surface extension, and slight parietal rigidity of the lesion. This allows one to predict correctly the degree of in-depth invasion in approximately 95% of cases. Only 3 of 64 lesions were underevaluated in our series and could thus have been responsible for a negative therapeutic consequence. This means that a well-trained endoscopist can differentiate an intramucosal from a submucosal carcinoma with a fairly high degree of accuracy.
As far as the detection ofmediastinal lymph node metastasis is concerned, only endoscopic ultrasonography (EUS) really is useful. Of 113 squamous cell carcinomas, Tio et al., (1989) demonstrated a positive correlation between EUS and histology in 100% of T and T2 esophageal cancers, whereas the rate was lower for T3 and T4 cancers. In the latter, the tumoral stenosis often prevents the progression of the EUS device beyond the tumor to examine the lymph nodes.
Overall, the accuracy ofthe pretreatment staging (tumor and lymph nodes) is approximately 82% with the EUS for T and T2 cancers. This figure drops to only 12% with CT.
In view of these data, it seems that our endoscopic staging system, combined with the endoscopic ultrasonography for the detection oflymph node metastases, represents the best pretherapy investigation to predict the future success of a pure endoscopic treatment of early esophageal carcinomas. EUS may further reinforce or invalidate the endoscopic staging of the primary tumor based on endoscopic criteria.
Treatment of Early Esophageal Cancer
In 1980, the early report of Earlam and Cunha-Melo (1980) Because of the greater availability of endoscopy, allowing diagnosis at an earlier stage, and of the expertise of some surgical centers, the prognosis and outcome of this dismal disease have steadily improved over the last decade. More radical resection procedures with posterior mediastinectomy (Akiyama et al., 1981; Lerut et al., 1992) , en bloc resection (Altorki and Skinner, 1990) , and three field dissections (Tsurumaru et al., 1990) have been developedto increase the chance for local control and cure.
If 5-year survival rates remain around 90% in stage I cancers (Lerut et al., 1992) , they are deceptively low for stage III and to a lesser extent for stage II lesions, at least in Western countries where tobacco and alcohol consumption plays a major role as risk factors. The debilitated patients, often presenting with multiple internal pathologies, represent poor surgical candidates.
Although some specialized centers in thoracic surgery report a resectability rate of 77% (Lerut et al., 1992) (Lerut et al., 1992; Altorki and Skinner, 1990; Gignoux and Segal, 1984) 
